A portrait of Zimmer Biomet CEO Bryan Hanson
Zimmer Biomet CEO Bryan Hanson [Photo courtesy Zimmer Biomet]

An unusually large share of Zimmer Biomet (NYSE:ZBH) investors voted against the orthopedics company’s pay packages for top executives at the annual shareholder meeting.

About 54 percent of voting shareholders supported the pay packages of the company’s five top-paid executives at the May 13 meeting, according to results filed with the SEC yesterday.

In 2021, nearly 93 percent of voting shareholders supported the executive compensation plan in what’s known as the Say on Pay vote, the company said in an SEC filing.

Get the full story at our sister site, Medical Design & Outsourcing.